OSTEOPOROSIS INTERNATIONAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2276425, encodeId=89bc22e6425e9, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一个月了，还在EA，想退坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15b99795648, createdName=ms1000000246434369, createdTime=Thu Aug 07 23:39:36 CST 2025, time=2025-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2274779, encodeId=c34022e47798e, content=Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jul 25 10:56:19 CST 2025, time=2025-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222815, encodeId=245e222281551, content=偏重的研究方向：骨质疏松;骨科 经验分享：Editor Assigne一个半月了有人知道咋回事嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Aug 28 13:18:15 CST 2024, time=2024-08-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2212971, encodeId=c30722129e17d, content=审稿速度:1.0 偏重的研究方向：骨质疏松症 经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae678498010, createdName=ms9000000602625829, createdTime=Wed Jul 03 13:45:18 CST 2024, time=2024-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192340, encodeId=950c219234083, content=感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Sun Mar 10 08:45:41 CST 2024, time=2024-03-10, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229324, encodeId=b3a41229324ac, content=越来越慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52f95311063, createdName=148895a5m97暂无昵称, createdTime=Wed Jun 29 01:26:03 CST 2022, time=2022-06-29, status=1, ipAttribution=)]

2025-08-07 ms1000000246434369 来自广东省

审稿速度:6.0 | 投稿命中率:25.0
经验分享：一个月了，还在EA，想退坑

26 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2276425, encodeId=89bc22e6425e9, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一个月了，还在EA，想退坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15b99795648, createdName=ms1000000246434369, createdTime=Thu Aug 07 23:39:36 CST 2025, time=2025-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2274779, encodeId=c34022e47798e, content=Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jul 25 10:56:19 CST 2025, time=2025-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222815, encodeId=245e222281551, content=偏重的研究方向：骨质疏松;骨科 经验分享：Editor Assigne一个半月了有人知道咋回事嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Aug 28 13:18:15 CST 2024, time=2024-08-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2212971, encodeId=c30722129e17d, content=审稿速度:1.0 偏重的研究方向：骨质疏松症 经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae678498010, createdName=ms9000000602625829, createdTime=Wed Jul 03 13:45:18 CST 2024, time=2024-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192340, encodeId=950c219234083, content=感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Sun Mar 10 08:45:41 CST 2024, time=2024-03-10, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229324, encodeId=b3a41229324ac, content=越来越慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52f95311063, createdName=148895a5m97暂无昵称, createdTime=Wed Jun 29 01:26:03 CST 2022, time=2022-06-29, status=1, ipAttribution=)]

2025-07-25 匿名用户

Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest.

25 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2276425, encodeId=89bc22e6425e9, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一个月了，还在EA，想退坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15b99795648, createdName=ms1000000246434369, createdTime=Thu Aug 07 23:39:36 CST 2025, time=2025-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2274779, encodeId=c34022e47798e, content=Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jul 25 10:56:19 CST 2025, time=2025-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222815, encodeId=245e222281551, content=偏重的研究方向：骨质疏松;骨科 经验分享：Editor Assigne一个半月了有人知道咋回事嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Aug 28 13:18:15 CST 2024, time=2024-08-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2212971, encodeId=c30722129e17d, content=审稿速度:1.0 偏重的研究方向：骨质疏松症 经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae678498010, createdName=ms9000000602625829, createdTime=Wed Jul 03 13:45:18 CST 2024, time=2024-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192340, encodeId=950c219234083, content=感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Sun Mar 10 08:45:41 CST 2024, time=2024-03-10, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229324, encodeId=b3a41229324ac, content=越来越慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52f95311063, createdName=148895a5m97暂无昵称, createdTime=Wed Jun 29 01:26:03 CST 2022, time=2022-06-29, status=1, ipAttribution=)]

2021-12-29 rayms

所有作者在文章接收之后都会接收到邮件吗？

169 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2276425, encodeId=89bc22e6425e9, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一个月了，还在EA，想退坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15b99795648, createdName=ms1000000246434369, createdTime=Thu Aug 07 23:39:36 CST 2025, time=2025-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2274779, encodeId=c34022e47798e, content=Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jul 25 10:56:19 CST 2025, time=2025-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222815, encodeId=245e222281551, content=偏重的研究方向：骨质疏松;骨科 经验分享：Editor Assigne一个半月了有人知道咋回事嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Aug 28 13:18:15 CST 2024, time=2024-08-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2212971, encodeId=c30722129e17d, content=审稿速度:1.0 偏重的研究方向：骨质疏松症 经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae678498010, createdName=ms9000000602625829, createdTime=Wed Jul 03 13:45:18 CST 2024, time=2024-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192340, encodeId=950c219234083, content=感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Sun Mar 10 08:45:41 CST 2024, time=2024-03-10, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229324, encodeId=b3a41229324ac, content=越来越慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52f95311063, createdName=148895a5m97暂无昵称, createdTime=Wed Jun 29 01:26:03 CST 2022, time=2022-06-29, status=1, ipAttribution=)]

2024-08-28 ms5000000983971375 来自陕西省

偏重的研究方向：骨质疏松;骨科
经验分享：Editor Assigne一个半月了有人知道咋回事嘛

90 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2276425, encodeId=89bc22e6425e9, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一个月了，还在EA，想退坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15b99795648, createdName=ms1000000246434369, createdTime=Thu Aug 07 23:39:36 CST 2025, time=2025-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2274779, encodeId=c34022e47798e, content=Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jul 25 10:56:19 CST 2025, time=2025-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222815, encodeId=245e222281551, content=偏重的研究方向：骨质疏松;骨科 经验分享：Editor Assigne一个半月了有人知道咋回事嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Aug 28 13:18:15 CST 2024, time=2024-08-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2212971, encodeId=c30722129e17d, content=审稿速度:1.0 偏重的研究方向：骨质疏松症 经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae678498010, createdName=ms9000000602625829, createdTime=Wed Jul 03 13:45:18 CST 2024, time=2024-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192340, encodeId=950c219234083, content=感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Sun Mar 10 08:45:41 CST 2024, time=2024-03-10, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229324, encodeId=b3a41229324ac, content=越来越慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52f95311063, createdName=148895a5m97暂无昵称, createdTime=Wed Jun 29 01:26:03 CST 2022, time=2022-06-29, status=1, ipAttribution=)]

2024-07-03 ms9000000602625829 来自江苏省

审稿速度:1.0
偏重的研究方向：骨质疏松症
经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？

100 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2276425, encodeId=89bc22e6425e9, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一个月了，还在EA，想退坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15b99795648, createdName=ms1000000246434369, createdTime=Thu Aug 07 23:39:36 CST 2025, time=2025-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2274779, encodeId=c34022e47798e, content=Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jul 25 10:56:19 CST 2025, time=2025-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222815, encodeId=245e222281551, content=偏重的研究方向：骨质疏松;骨科 经验分享：Editor Assigne一个半月了有人知道咋回事嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Aug 28 13:18:15 CST 2024, time=2024-08-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2212971, encodeId=c30722129e17d, content=审稿速度:1.0 偏重的研究方向：骨质疏松症 经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae678498010, createdName=ms9000000602625829, createdTime=Wed Jul 03 13:45:18 CST 2024, time=2024-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192340, encodeId=950c219234083, content=感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Sun Mar 10 08:45:41 CST 2024, time=2024-03-10, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229324, encodeId=b3a41229324ac, content=越来越慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52f95311063, createdName=148895a5m97暂无昵称, createdTime=Wed Jun 29 01:26:03 CST 2022, time=2022-06-29, status=1, ipAttribution=)]

2024-03-10 wrc123 来自新南威尔士

感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了

121 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2276425, encodeId=89bc22e6425e9, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一个月了，还在EA，想退坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15b99795648, createdName=ms1000000246434369, createdTime=Thu Aug 07 23:39:36 CST 2025, time=2025-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2274779, encodeId=c34022e47798e, content=Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jul 25 10:56:19 CST 2025, time=2025-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222815, encodeId=245e222281551, content=偏重的研究方向：骨质疏松;骨科 经验分享：Editor Assigne一个半月了有人知道咋回事嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Aug 28 13:18:15 CST 2024, time=2024-08-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2212971, encodeId=c30722129e17d, content=审稿速度:1.0 偏重的研究方向：骨质疏松症 经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae678498010, createdName=ms9000000602625829, createdTime=Wed Jul 03 13:45:18 CST 2024, time=2024-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192340, encodeId=950c219234083, content=感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Sun Mar 10 08:45:41 CST 2024, time=2024-03-10, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229324, encodeId=b3a41229324ac, content=越来越慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52f95311063, createdName=148895a5m97暂无昵称, createdTime=Wed Jun 29 01:26:03 CST 2022, time=2022-06-29, status=1, ipAttribution=)]

2022-06-03 ms1000001687207454

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：骨质疏松
经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。

156 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2276425, encodeId=89bc22e6425e9, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一个月了，还在EA，想退坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15b99795648, createdName=ms1000000246434369, createdTime=Thu Aug 07 23:39:36 CST 2025, time=2025-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2274779, encodeId=c34022e47798e, content=Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jul 25 10:56:19 CST 2025, time=2025-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222815, encodeId=245e222281551, content=偏重的研究方向：骨质疏松;骨科 经验分享：Editor Assigne一个半月了有人知道咋回事嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Aug 28 13:18:15 CST 2024, time=2024-08-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2212971, encodeId=c30722129e17d, content=审稿速度:1.0 偏重的研究方向：骨质疏松症 经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae678498010, createdName=ms9000000602625829, createdTime=Wed Jul 03 13:45:18 CST 2024, time=2024-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192340, encodeId=950c219234083, content=感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Sun Mar 10 08:45:41 CST 2024, time=2024-03-10, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229324, encodeId=b3a41229324ac, content=越来越慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52f95311063, createdName=148895a5m97暂无昵称, createdTime=Wed Jun 29 01:26:03 CST 2022, time=2022-06-29, status=1, ipAttribution=)]

2022-02-09 ms6000000498436311

偏重的研究方向：骨质疏松
经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！

176 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2276425, encodeId=89bc22e6425e9, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一个月了，还在EA，想退坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15b99795648, createdName=ms1000000246434369, createdTime=Thu Aug 07 23:39:36 CST 2025, time=2025-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2274779, encodeId=c34022e47798e, content=Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jul 25 10:56:19 CST 2025, time=2025-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222815, encodeId=245e222281551, content=偏重的研究方向：骨质疏松;骨科 经验分享：Editor Assigne一个半月了有人知道咋回事嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Aug 28 13:18:15 CST 2024, time=2024-08-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2212971, encodeId=c30722129e17d, content=审稿速度:1.0 偏重的研究方向：骨质疏松症 经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae678498010, createdName=ms9000000602625829, createdTime=Wed Jul 03 13:45:18 CST 2024, time=2024-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192340, encodeId=950c219234083, content=感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Sun Mar 10 08:45:41 CST 2024, time=2024-03-10, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229324, encodeId=b3a41229324ac, content=越来越慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52f95311063, createdName=148895a5m97暂无昵称, createdTime=Wed Jun 29 01:26:03 CST 2022, time=2022-06-29, status=1, ipAttribution=)]

2022-09-26 ms6000000510226862

2022年6月17日投稿，6月30日至今reviewers assigned

146 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2276425, encodeId=89bc22e6425e9, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一个月了，还在EA，想退坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15b99795648, createdName=ms1000000246434369, createdTime=Thu Aug 07 23:39:36 CST 2025, time=2025-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2274779, encodeId=c34022e47798e, content=Competing Interests:列出每一位作者，eg:A, B and C declare that they have no conflict of interest., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jul 25 10:56:19 CST 2025, time=2025-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095821, encodeId=057a1095821a0, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2222815, encodeId=245e222281551, content=偏重的研究方向：骨质疏松;骨科 经验分享：Editor Assigne一个半月了有人知道咋回事嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Wed Aug 28 13:18:15 CST 2024, time=2024-08-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2212971, encodeId=c30722129e17d, content=审稿速度:1.0 偏重的研究方向：骨质疏松症 经验分享：5.9号投稿，5.29号Reviewers Assigned，6月2号under review，6.20号小修，7.1号修回，7.2号又Reviewers Assigned，请问这个杂志修回还会再次送新的审稿人吗？还是给原来的审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae678498010, createdName=ms9000000602625829, createdTime=Wed Jul 03 13:45:18 CST 2024, time=2024-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192340, encodeId=950c219234083, content=感觉不好，首先new submission 到 editor assigned 就要两周，然后editor assigned 就有将近一个月，拒了我，没写任何观点，感觉杂志很傲慢，不会再投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3b5560638, createdName=wrc123, createdTime=Sun Mar 10 08:45:41 CST 2024, time=2024-03-10, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=1224241, encodeId=00eb1224241a2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨质疏松 经验分享：2022年3月3日投的稿，4月份左右修回（小修），给了3个月的时间修改，但我一周左右修好并提交，5月初审稿结束，过了约2周时间给出决定接收。审稿专家心很细，提了十几条意见，受益匪浅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Fri Jun 03 13:10:23 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191487, encodeId=3905119148e33, content=偏重的研究方向：骨质疏松 经验分享：请问有谁知道 editorial manager 上面本来under review 的状态近三周之后变回了reviewer assigned 是什么情况吗？我可以发邮件问编辑吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea56429884, createdName=ms6000000498436311, createdTime=Wed Feb 09 18:27:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090490, encodeId=7dfe2090490ff, content=2022年6月17日投稿，6月30日至今reviewers assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ef8259266, createdName=ms6000000510226862, createdTime=Mon Sep 26 19:07:27 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229324, encodeId=b3a41229324ac, content=越来越慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52f95311063, createdName=148895a5m97暂无昵称, createdTime=Wed Jun 29 01:26:03 CST 2022, time=2022-06-29, status=1, ipAttribution=)]

2022-06-29 148895a5m97暂无昵称

越来越慢了

154 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务